BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16117679)

  • 1. Functional identification of cancer-relevant genes through large-scale RNA interference screens in mammalian cells.
    Brummelkamp TR; Berns K; Hijmans EM; Mullenders J; Fabius A; Heimerikx M; Velds A; Kerkhoven RM; Madiredjo M; Bernards R; Beijersbergen RL
    Cold Spring Harb Symp Quant Biol; 2004; 69():439-45. PubMed ID: 16117679
    [No Abstract]   [Full Text] [Related]  

  • 2. A resource for large-scale RNA-interference-based screens in mammals.
    Paddison PJ; Silva JM; Conklin DS; Schlabach M; Li M; Aruleba S; Balija V; O'Shaughnessy A; Gnoj L; Scobie K; Chang K; Westbrook T; Cleary M; Sachidanandam R; McCombie WR; Elledge SJ; Hannon GJ
    Nature; 2004 Mar; 428(6981):427-31. PubMed ID: 15042091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large-scale RNAi screen in human cells identifies new components of the p53 pathway.
    Berns K; Hijmans EM; Mullenders J; Brummelkamp TR; Velds A; Heimerikx M; Kerkhoven RM; Madiredjo M; Nijkamp W; Weigelt B; Agami R; Ge W; Cavet G; Linsley PS; Beijersbergen RL; Bernards R
    Nature; 2004 Mar; 428(6981):431-7. PubMed ID: 15042092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. shRNA libraries and their use in cancer genetics.
    Bernards R; Brummelkamp TR; Beijersbergen RL
    Nat Methods; 2006 Sep; 3(9):701-6. PubMed ID: 16929315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference: human genes hit the big screen.
    Fraser A
    Nature; 2004 Mar; 428(6981):375-8. PubMed ID: 15042071
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatically prepared RNAi libraries.
    Buchholz F; Kittler R; Slabicki M; Theis M
    Nat Methods; 2006 Sep; 3(9):696-700. PubMed ID: 16929314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A universal plasmid library encoding all permutations of small interfering RNA.
    Chen M; Zhang L; Zhang HY; Xiong X; Wang B; Du Q; Lu B; Wahlestedt C; Liang Z
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2356-61. PubMed ID: 15695593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-scale loss-of-function screening with a lentiviral RNAi library.
    Root DE; Hacohen N; Hahn WC; Lander ES; Sabatini DM
    Nat Methods; 2006 Sep; 3(9):715-9. PubMed ID: 16929317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of ovarian cancer growth by small interfering RNA targeting X-linked inhibitor of apoptosis gene].
    Ma JJ; Chen BL; Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):124-8. PubMed ID: 17442189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget therapy of malignant cancers by the head-to-tail tandem array multiple shRNAs expression system.
    Cheng TL; Teng CF; Tsai WH; Yeh CW; Wu MP; Hsu HC; Hung CF; Chang WT
    Cancer Gene Ther; 2009 Jun; 16(6):516-31. PubMed ID: 19165234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Cancer Gene Ther; 2009 Jun; 16(6):532-8. PubMed ID: 19165236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
    Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
    Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer.
    Mullenders J; Bernards R
    Oncogene; 2009 Dec; 28(50):4409-20. PubMed ID: 19767776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
    Huang ZG; Ran ZH; Lu W; Xiao SD
    Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of pathogenetically relevant genes in lymphomagenesis by shRNA library screens.
    Ngo VN
    Methods Mol Biol; 2013; 971():245-63. PubMed ID: 23296968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vector-mediated HER-2 RNA interference against HER-2-positive breast cancer].
    Hu XQ; Qin L; Su FX; Yao HR; Chen JS; Gong C; Guo JJ; Yu FY; Jia HX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):570-2. PubMed ID: 16762851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells.
    Downward J
    Oncogene; 2004 Nov; 23(51):8376-83. PubMed ID: 15517019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vector systems of RNA interference].
    Kazachenko KIu; Avdonin PV
    Ontogenez; 2006; 37(3):163-70. PubMed ID: 16813217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A probability-based approach for the analysis of large-scale RNAi screens.
    König R; Chiang CY; Tu BP; Yan SF; DeJesus PD; Romero A; Bergauer T; Orth A; Krueger U; Zhou Y; Chanda SK
    Nat Methods; 2007 Oct; 4(10):847-9. PubMed ID: 17828270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.
    Visser S; Yang X
    Gene; 2010 Jan; 449(1-2):22-9. PubMed ID: 19799973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.